Side-by-side comparison of AI visibility scores, market position, and capabilities
Healthcare AI finance; raised $27M Series A (GV, March 2026); agentic AI automates 97% of hospital revenue cycle analysis; targets prior auth, claims, and denial management workflows
Translucent is a healthcare financial technology company building agentic AI systems that automate the complex, high-volume financial workflows that consume enormous resources inside hospital systems and health plans. Founded to address the inefficiency of healthcare revenue cycle management — a process involving prior authorizations, claims adjudication, denial management, and payment reconciliation — Translucent deploys AI agents that can perform end-to-end financial analysis tasks that previously required large teams of specialists.\n\nThe company's platform is designed around autonomous AI agents that can navigate healthcare-specific financial processes: reading payer contracts, interpreting remittance advice, identifying underpayments, managing denials, and forecasting revenue. Translucent's approach is agentic rather than assisted — the system is designed to complete routine financial analysis tasks without human intervention, not just surface information for a human to act on. Its customers include health systems, physician groups, and managed care organizations dealing with the complexity of multi-payer revenue environments.\n\nTranslucent has achieved a notable benchmark: 97% of routine financial analysis tasks are now fully automated on its platform, a metric that speaks directly to the ROI argument for health system CFOs and revenue cycle leaders. The company raised a $27M Series A from GV (Google Ventures) in March 2026, validating both its technical approach and its commercial traction. GV's investment reflects growing conviction that healthcare finance is one of the highest-value targets for agentic AI automation, given the complexity, volume, and cost of the current manual-heavy process.
Armonk NY hybrid cloud and enterprise AI (NYSE: IBM) at $62.8B revenue; $6B+ generative AI bookings, record $12.7B free cash flow 2024, DataStax acquisition for watsonx vector database competing with Microsoft Azure for enterprise AI.
International Business Machines Corporation (IBM) is an Armonk, New York-based global technology and consulting company — publicly traded on the New York Stock Exchange (NYSE: IBM) as an S&P 500 component — providing hybrid cloud infrastructure, artificial intelligence software, and enterprise IT consulting through approximately 270,300 employees in 170 countries with $62.8 billion in annual revenue. Founded on June 16, 1911, as Computing-Tabulating-Recording Company through a merger orchestrated by financier Charles Ranlett Flint, renamed IBM in 1924 under Thomas Watson Sr., IBM has undergone multiple strategic transformations over its 110+ year history: building the System/360 mainframe platform (1964), launching the IBM PC (1981), selling the PC division to Lenovo (2005, $1.75B), and completing the $34 billion Red Hat acquisition (2019) that repositioned IBM as a hybrid cloud platform company. CEO Arvind Krishna (appointed April 2020) has focused IBM's strategy on three areas: hybrid cloud (powered by Red Hat OpenShift, the enterprise Kubernetes platform), AI (the watsonx platform for enterprise AI model development and deployment), and enterprise consulting. Under Krishna, IBM recorded $12.7 billion in free cash flow in 2024 (a company record), surpassed $6 billion in generative AI bookings since June 2023, and saw the stock price double — trading at all-time highs through 2024-2025. IBM announced the DataStax acquisition in 2025 to deepen watsonx's data layer with AstraDB (vector database for AI applications), DataStax Enterprise (Apache Cassandra), and Langflow (low-code AI agent development).
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.